8/12/2019 Gillian Lockwood - Subcutaneous Progesterone - II Simposio Reproduccin Asistida Quirn

1/29

Run-but`egcus prcagstgrceg4

tmg ngst ci nctm wcrfos 3

Or Ahffh`e Fcbjwcco

Khof`eo Igrthfhty Rgrvhbgs

@forhoag - Qgst Khof`eos - Wehtgo Jheaock

Hf Rhkpcshc ^gprcoubbhce @shstho`

K`orho >0 Ignrgrc >

8/12/2019 Gillian Lockwood - Subcutaneous Progesterone - II Simposio Reproduccin Asistida Quirn

2/29

Qcrfowhogusg ci Futg`f\m`sg Ruppcrt

Y`hsnubm gt `f. ( >)

8/12/2019 Gillian Lockwood - Subcutaneous Progesterone - II Simposio Reproduccin Asistida Quirn

3/29

Egw `qugcus prcagstgrceg

prgp`r`thce icr h.k. `eo

s.b. `okhehstr`thce

Myorcscfunhfhty ci prcagstgrceg gem`ebgo

ny -bybfcogxtrhes(-BOs)

prcoubts ci st`rbm gezyk`thb ogar`o`thce, bcet`hehea

shx tc ghamt afubcsg uehts dchego he ` rhea ny

-0? afybcshohb nceos

_mgsg bckpcueos `rg whogfy usgo tc scfunhfhsg

ece-pcf`r bckpcueos `eo tc hkprcvg tmg `nscrpthce `eo

ohstrhnuthce ci ece-pcf`r kgohbhe`f prcoubts

2

8/12/2019 Gillian Lockwood - Subcutaneous Progesterone - II Simposio Reproduccin Asistida Quirn

4/29

M\gt`-Bybfcogxtrhe

B`pphea

?

8/12/2019 Gillian Lockwood - Subcutaneous Progesterone - II Simposio Reproduccin Asistida Quirn

5/29

Jhegthb \rcihfg ci -bybfcogxtrhes (-

BOs) `itgr sheafg ocsg `okhehstr`thce

ci 0 < 7 shtgs

Muea`ry4 0 shtg

_ct`f4 02 hesthtuthces

8/12/2019 Gillian Lockwood - Subcutaneous Progesterone - II Simposio Reproduccin Asistida Quirn

9/29

Rtuoy Rhtgs

_ct`f4 = hesthtuthces

Nchsg, HO

Rg`ttfg, Q@

Ngoicro, _]

Crf`eoc, IF

Rt`eicro, B@_mcus`eos C`js, B@

R`e Dcsg, B@

^goceoc Ng`bm, B@

8/12/2019 Gillian Lockwood - Subcutaneous Progesterone - II Simposio Reproduccin Asistida Quirn

10/29

\rhk`ry Cutbckg Y`rh`nfg

Ceachea prgae`eby r`tg `t tmg geo ci tmg stuoy (0< wggjs

ci futg`f suppcrt), ogihego `s tmg pgrbget`ag ci gknryc-

tr`esigrrgo p`thgets whtm `t fg`st ceg igt`f mg`rtng`t.

Rt`thsthb`f @e`fyshs4

Ece-heigrhcrhty w`s `ssgssgo ny b`fbuf`thea tmg 87% bceihogebg

hetgrv`f (BH) ci tmg ohiigrgebg ngtwgge tmgprgae`eby r`tgs icr tmg twc

trg`tkget arcup.

Hi tmg fcwgr ncueo ci tmg 87% BH ci tmg ohiigrgebg w`s arg`tgr tm`e

8/12/2019 Gillian Lockwood - Subcutaneous Progesterone - II Simposio Reproduccin Asistida Quirn

11/29

Rgbceo`ry Cutbckg Y`rh`nfgs

Hkpf`et`thce r`tg

Hebhogebg ci pcshthvg sgruk prgae`eby

tgsts

Bfhehb`f prgae`eby r`tg

Fhvg nhrtm r`tg

G`rfy spcet`egcus `ncrthces

8/12/2019 Gillian Lockwood - Subcutaneous Progesterone - II Simposio Reproduccin Asistida Quirn

12/29

K`he Hebfushce Brhtgrh`

NKH 6 2< ja/k>:

@ag 0= - ?> (upce st`rthea BCR):

62 prhcr @^_ bybfgs (HYI, HBRH `eo rgf`tgo

prcbgourgs):

N`sgfheg (o`y >-2 ci bybfhea) IRM 607 HW/F

`eo G> 6=< pa/kF:

Ecrk`f utgrheg b`vhty `s pgr rgbget

mystgrcs`fpheacar`k, scecmystcar`k cr

mystgrcsbcphb gx`k (h.g. ec pcfyps cr

prctruohea sunkubcs`f ihnrchos).

8/12/2019 Gillian Lockwood - Subcutaneous Progesterone - II Simposio Reproduccin Asistida Quirn

13/29

K`he Gxbfushce Brhtgrh`

Hetr`kur`f utgrheg ihnrchos tm`t ohstcrt tmg utgrhegb`vhty cr pcfyps 50 bk:

Rt`ag HHH cr HY geockgtrhcshs (ec geockgtrhck`s):

Myorcs`fpheags:

Mhstcry ci p`st pccr rgspcesg tc BCM rgsufthea heb`ebgffhea @^_:

Webcetrcffgo `orge`f cr tmyrcho oysiuebthce:

Mhstcry ci rgburrget prgae`eby fcss ogihego `s 2 crkcrg spcet`egcus khsb`rrh`ags, wmgrghe prgae`ebyogvgfcpgo tc ` khehkuk ci ` agst`thce`f s`b ce _YWR

8/12/2019 Gillian Lockwood - Subcutaneous Progesterone - II Simposio Reproduccin Asistida Quirn

14/29

Rtuoy \rctcbcf

HYI cr HBRH

@ey BCM prctcbcf

\`thgets wmc prcvhogo `t fg`st 2 ccbytgs wgrg

r`eockhsgo

Ihrst ocsg `okhehstgrgo ce tmg o`y ci C\W

O`hfy trg`tkget w`s bcetheugo icr ` tct`f ci 07>

o`ys, `t wmhbm thkg ` sgruk prgae`eby tgst w`s

pgricrkgo

He tmg gvget ci ` pcshthvg prgae`eby tgstrgsuft

`eo sunsgquget bceihrk`thce ci ceachea

prgae`eby, trg`tkget w`s tc ng bcetheugo icr up

tc 0< wggjs (h.g. up tc tmg 0> wggjs ci agst`thce)

\rgae`eby cutbckg icrk icffcwhea ogfhvgry

8/12/2019 Gillian Lockwood - Subcutaneous Progesterone - II Simposio Reproduccin Asistida Quirn

15/29

N`sgfheg Bm`r`btgrhsthbs

Y`rh`nfg GW stuoy WR@ stuoy

Kg`e (RO)\rca s.b.

(e;22?)

\rca Y`a Agf

(e;22?)

\ \rca s.b.

(e;28>)

\ Y a \gss`ry

(e;28.= (2.0?) >2.< (2.0?) 2.? (2.0) >2.7 (2.

8/12/2019 Gillian Lockwood - Subcutaneous Progesterone - II Simposio Reproduccin Asistida Quirn

16/29

B`usgs ci Heigrthfhty

Y`rh`nfg Gurcpg`e stuoy WR@ stuoy

(%)\rca s.b.

(e;22?)

\rca Y`a Agf

(e;22?)p

\rca s.b.

(e;28>)

\ Y`a \gss

(e;28.= >2.< >>.9

8/12/2019 Gillian Lockwood - Subcutaneous Progesterone - II Simposio Reproduccin Asistida Quirn

17/29

_rg`tkget \rcar`kkhea

`eo Ocwe-^gauf`thce

Kgohb`thce

_ypg `eo Orua (%)

\rca. s.b.

(e;22?)

\rca. Y`a Agf

(e;22?)

\

v`fug

Bybfg syebmrcehs`thce

Cr`f bcetr`bgpthvg 2.8 2.8 0.

8/12/2019 Gillian Lockwood - Subcutaneous Progesterone - II Simposio Reproduccin Asistida Quirn

18/29

_rg`tkget \rcar`kkhea

`eo Ocwe-^gauf`thce

Kgohb`thce

_ypg @eo Orua (%)

\rca s.b.

(e;28>)

\ Y a \gss`ry

(e;28

8/12/2019 Gillian Lockwood - Subcutaneous Progesterone - II Simposio Reproduccin Asistida Quirn

19/29

Cv`rh`e Rthkuf`thce

Kgohb`thce

_ypg `eo Orua (%)

\rca s.b.

(e;22?)

\rca Y`a Agf

(e;22?)

\

v`fug

^gb IRM ?1.8 ?7.7

.2 27

^gb-IRM + MKA >.1 >.1

^gb-IRM + ^gb FM >.0

8/12/2019 Gillian Lockwood - Subcutaneous Progesterone - II Simposio Reproduccin Asistida Quirn

20/29

Cv`rh`e Rthkuf`thce

Kgohb`thce

_ypg `eo Orua (%)

\rca s.b.

(e;28>)

\rca Y`a \gss`ry

(e;28.9 >.0

8/12/2019 Gillian Lockwood - Subcutaneous Progesterone - II Simposio Reproduccin Asistida Quirn

21/29

^gtrhgvgo ccbytgs

Y`rh`nfg ZKg`e (RO)[\rca. s.b.

(e;22?)

\rca.Y`a Agf

(e;22?)p

_ct`f IRM, HW >?

8/12/2019 Gillian Lockwood - Subcutaneous Progesterone - II Simposio Reproduccin Asistida Quirn

22/29

^gtrhgvgo ccbytgs

Y`rh`nfg ZKg`e (RO)[\rca s.b.

(e;28>)

\rca Y`a \gss`ry

(e;28009 (008? (0008)

Er ccbytgs rgtrhgvgo 09.7 (=.=) 07.9 (=. (

8/12/2019 Gillian Lockwood - Subcutaneous Progesterone - II Simposio Reproduccin Asistida Quirn

23/29

7 >? 0>.7 >2 22.7

1 20 2>.2 >= ?>.8

= 9? 20.2 9? >8.18 02 ?9.> 02 98.>

0< >> ?.9 >2 >9.0

00 7 < 7 > >= 72.9 >1 =.7

8/12/2019 Gillian Lockwood - Subcutaneous Progesterone - II Simposio Reproduccin Asistida Quirn

26/29

@ssgsskget E (%) \rca s.b. \rca Y`a Agf \ v`fug

Bckicrt

Ygry uebckicrt`nfg > ()

Egutr`f 9> (>>.2)

Bckicrt`nfg 010 (79.2) 097 (72.?)

Ygry bckicrt`nfg ?9 (07.0) 72 (01.>)

Bckicrt

8/12/2019 Gillian Lockwood - Subcutaneous Progesterone - II Simposio Reproduccin Asistida Quirn

27/29

R`igty

Y`rh`nfg (%) \rca s.b.

(e;?

8/12/2019 Gillian Lockwood - Subcutaneous Progesterone - II Simposio Reproduccin Asistida Quirn

28/29

Bcebfushces

_mgsg twc f`rag, prcspgbthvg r`eockhsgo stuohgsogkcestr`tg tm`t >7 ka sunbut`egcus prcagstgrceg

`okhehstgrgo cebg o`hfy hs nctm giigbthvg `eo wgff

tcfgr`tgo he ` v`rhgty ci BCR prctcbcfs.

_mgrgicrg, sunbut`egcus prcagstgrceg rgprgsgets `

v`fu`nfg `ftgre`thvg cpthce icr futg`f pm`sg suppcrt he

`sshstgo rgprcoubthce, wmgrg p`rgetgr`f `okhehstr`thce

hs prgigrrgo cr rgquhrgo.

8/12/2019 Gillian Lockwood - Subcutaneous Progesterone - II Simposio Reproduccin Asistida Quirn

29/29

_m`ej ycu icr ycur `ttgethce.

www.khof`eoigrthfhty.bck